Appeals court upholds patent on Merck's Vytorin

WASHINGTON (Reuters) - A U.S. appeals court on Thursday ruled that the patent on Merck & Co's cholesterol fighter Zetia and a related drug, Vytorin, was valid.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news